Drugs / FK506MR
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00619398 | Jan 2008 → Mar 2009 | — | Astellas Pharma Inc | Completed | No outcome recorded |
| Phase 3 | NCT00481819 | Jul 2007 → Mar 2009 | — | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FK506MR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00619398 ↗ |